Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine-- Nykode Therapeutics said Friday it initiated the phase 2 clinical trial VB-C-04 for its therapeutic cancer vaccine candidate for HPV16-positive cancers. The off-the-shelf vaccine is used alone or...